Patents by Inventor Scott R. Stanslaski

Scott R. Stanslaski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220032063
    Abstract: Devices, systems, and techniques are described for identifying stimulation parameter values based on electrical stimulation that induces dyskinesia for the patient. For example, a method may include controlling, by processing circuitry, a medical device to deliver electrical stimulation to a portion of a brain of a patient, receiving, by the processing circuitry, information representative of an electrical signal sensed from the brain after delivery of the electrical stimulation, determining, by the processing circuitry and from the information representative of the electrical signal, a peak in a spectral power of the electrical signal at a second frequency lower than a first frequency of the electrical stimulation, and responsive to determining the peak in the spectral power of the electrical signal at the second frequency, performing, by the processing circuitry, an action.
    Type: Application
    Filed: July 31, 2020
    Publication date: February 3, 2022
    Inventors: Rene A. Molina, Scott R. Stanslaski, Jadin C. Jackson, Christopher L. Pulliam, Eric J. Panken, Michelle A. Case, Abbey Beuning Holt Becker
  • Publication number: 20220032059
    Abstract: Devices, systems, and techniques are described for identifying stimulation parameter values based on electrical stimulation that induces dyskinesia for the patient. For example, a method may include controlling, by processing circuitry, a medical device to deliver electrical stimulation to a portion of a brain of a patient, receiving, by the processing circuitry, information representative of an electrical signal sensed from the brain after delivery of the electrical stimulation, determining, by the processing circuitry and from the information representative of the electrical signal, a peak in a spectral power of the electrical signal at a second frequency lower than a first frequency of the electrical stimulation, and responsive to determining the peak in the spectral power of the electrical signal at the second frequency, performing, by the processing circuitry, an action.
    Type: Application
    Filed: July 31, 2020
    Publication date: February 3, 2022
    Inventors: Rene A. Molina, Scott R. Stanslaski, Jadin C. Jackson, Christopher L. Pulliam, Eric J. Panken, Michelle A. Case, Abbey Beuning Holt Becker
  • Publication number: 20220008730
    Abstract: Devices, systems, and techniques for controlling electrical stimulation therapy are described. In one example, a system may be configured to deliver electrical stimulation therapy to a patient, the electrical stimulation therapy comprising a plurality of therapy pulses at a predetermined pulse frequency over a period of time and deliver, over the period of time, a plurality of control pulses interleaved with at least some therapy pulses of the plurality of therapy pulses. The system may also be configured to sense, after one or more control pulses and prior to an immediately subsequent therapy pulse of the plurality of therapy pulses, a respective evoked compound action potential (ECAP), adjust, based on at least one respective ECAP, one or more parameter values that at least partially defines the plurality of therapy pulses, and deliver the electrical stimulation therapy to the patient according to the adjusted one or more parameter values.
    Type: Application
    Filed: September 24, 2021
    Publication date: January 13, 2022
    Inventors: David A. Dinsmoor, Heather Diane Orser, Scott R. Stanslaski, Erik J. Peterson
  • Publication number: 20210361213
    Abstract: Devices and methods provide for the sensing of physiological signals during stimulation therapy by preventing stimulation waveform artifacts from being passed through to the amplification of the sensed physiological signal. Thus, the amplifiers are not adversely affected by the stimulation waveform and can provide for successful sensing of physiological signals between stimulation waveform pulses. A blanking switch may be used to blank the stimulation waveform artifacts where the blanking switch is operated in a manner synchronized with the stimulation waveform so that conduction in the sensing path is blocked during the stimulation pulse as well as during other troublesome artifacts such as a peak of a recharge pulse. A limiter may be used to limit the amplitude of the sensed signal, and hence the stimulation artifacts, that are passed to the amplifier without any synchronization of the limiter to the stimulation waveform.
    Type: Application
    Filed: August 4, 2021
    Publication date: November 25, 2021
    Inventors: Scott R. Stanslaski, Peng Cong, Wesley A. Santa, Timothy J. Denison
  • Publication number: 20210322770
    Abstract: In some examples of selecting a target therapy delivery site for treating a patient condition, a relatively high frequency electrical stimulation signal is delivered to at least two areas within a first region (e.g., an anterior nucleus of the thalamus) of a brain of a patient, and changes in brain activity (e.g., as indicated by bioelectrical brain signals) within a second region (e.g., a hippocampus) of the brain of the patient in response to the delivered stimulation are determined. The target therapy delivery site, an electrode combination, or both, may be selected based on the changes in brain activity.
    Type: Application
    Filed: June 30, 2021
    Publication date: October 21, 2021
    Inventors: Jonathon E. Giftakis, Timothy J. Denison, Paul H. Stypulkowski, Scott R. Stanslaski, Robert S. Raike, Mae Eng, David E. Linde, Thomas Adamski
  • Patent number: 11141591
    Abstract: Techniques, devices, and systems for isolating, by isolation circuitry connected to a power source, a voltage from the power source, receiving, by sensing circuitry, the isolated voltage, receiving, by the sensing circuitry, a reference voltage from an implantable reference electrode via a reference node, and sensing, by the sensing circuitry, the biomedical signal with two or more implantable sensing electrodes using the isolated voltage with respect to the reference voltage.
    Type: Grant
    Filed: December 26, 2018
    Date of Patent: October 12, 2021
    Assignee: Medtronic, Inc.
    Inventors: David A. Dinsmoor, Scott R. Stanslaski, Erik J. Peterson, Paul R. Mazanec
  • Patent number: 11129989
    Abstract: Devices, systems, and techniques for controlling electrical stimulation therapy are described. In one example, a system may be configured to deliver electrical stimulation therapy to a patient, the electrical stimulation therapy comprising a plurality of therapy pulses at a predetermined pulse frequency over a period of time and deliver, over the period of time, a plurality of control pulses interleaved with at least some therapy pulses of the plurality of therapy pulses. The system may also be configured to sense, after one or more control pulses and prior to an immediately subsequent therapy pulse of the plurality of therapy pulses, a respective evoked compound action potential (ECAP), adjust, based on at least one respective ECAP, one or more parameter values that at least partially defines the plurality of therapy pulses, and deliver the electrical stimulation therapy to the patient according to the adjusted one or more parameter values.
    Type: Grant
    Filed: June 21, 2019
    Date of Patent: September 28, 2021
    Assignee: Medtronic, Inc.
    Inventors: David A. Dinsmoor, Heather Diane Orser, Scott R. Stanslaski, Erik J. Peterson
  • Patent number: 11103172
    Abstract: Devices and methods provide for the sensing of physiological signals during stimulation therapy by preventing stimulation waveform artifacts from being passed through to the amplification of the sensed physiological signal. Thus, the amplifiers are not adversely affected by the stimulation waveform and can provide for successful sensing of physiological signals between stimulation waveform pulses. A blanking switch may be used to blank the stimulation waveform artifacts where the blanking switch is operated in a manner synchronized with the stimulation waveform so that conduction in the sensing path is blocked during the stimulation pulse as well as during other troublesome artifacts such as a peak of a recharge pulse. A limiter may be used to limit the amplitude of the sensed signal, and hence the stimulation artifacts, that are passed to the amplifier without any synchronization of the limiter to the stimulation waveform.
    Type: Grant
    Filed: October 28, 2013
    Date of Patent: August 31, 2021
    Assignee: MEDTRONIC, INC.
    Inventors: Scott R. Stanslaski, Peng Cong, Wesley A. Santa, Timothy J. Denison
  • Patent number: 11077305
    Abstract: In some examples of selecting a target therapy delivery site for treating a patient condition, a relatively high frequency electrical stimulation signal is delivered to at least two areas within a first region (e.g., an anterior nucleus of the thalamus) of a brain of a patient, and changes in brain activity (e.g., as indicated by bioelectrical brain signals) within a second region (e.g., a hippocampus) of the brain of the patient in response to the delivered stimulation are determined. The target therapy delivery site, an electrode combination, or both, may be selected based on the changes in brain activity.
    Type: Grant
    Filed: September 8, 2017
    Date of Patent: August 3, 2021
    Assignee: MEDTRONIC, INC.
    Inventors: Jonathon E. Giftakis, Timothy J. Denison, Paul H. Stypulkowski, Scott R. Stanslaski, Robert S. Raike, Mae Eng, David E. Linde, Thomas Adamski
  • Publication number: 20210228883
    Abstract: Techniques, systems, and devices are disclosed for delivering stimulation therapy to a patient. In one example, a medical device determines a first set of stimulation parameters that define entrainment stimulation pulses configured to entrain electrical activity in a patient. The medical device may control a stimulation generator to generate the entrainment stimulation pulses according to the first set of stimulation parameters. The medical device may further determine a second set of stimulation parameters that define at least one desynchronization stimulation pulse configured to disrupt at least a portion of the electrical activity entrained by the entrainment stimulation pulses. The medical device may subsequently control the stimulation generator to generate the desynchronization stimulation pulse(s) according to the second set of stimulation parameters.
    Type: Application
    Filed: January 24, 2020
    Publication date: July 29, 2021
    Inventors: Rene A. Molina, Robert S. Raike, Scott R. Stanslaski
  • Publication number: 20210205623
    Abstract: A system provides a burr hole cap assembly configured to secure a position of a lead implanted through a burr hole in a cranium of a patient. One or more electrodes are coupled to one or more components of the burr hole cap assembly. The one or more electrode is disposed within the burr hole cap assembly for sensing signals within a brain of the patient or stimulating a portion of the brain of the patient.
    Type: Application
    Filed: December 29, 2020
    Publication date: July 8, 2021
    Inventors: Erik J. Peterson, Scott R. Stanslaski, Alan Shi
  • Publication number: 20210196964
    Abstract: Devices, systems, and techniques are disclosed for managing electrical stimulation therapy and/or sensing of physiological signals such as brain signals. For example, a system may assist a clinician in identifying one or more electrode combinations for sensing a brain signal. In another example, a user interface may display brain signal information and values of a stimulation parameter at least partially defining electrical stimulation delivered to a patient when the brain signal information was sensed.
    Type: Application
    Filed: December 31, 2020
    Publication date: July 1, 2021
    Inventors: Evan D. Schnell, Scott R. Stanslaski, Ilan D. Gordon, Steven M. Goetz, Hijaz M. Haris, Eric J. Panken, Timothy R. Abraham, Thomas L. Chouinard, Susan E. Heilman Kilbane, Karan Chitkara, Christopher M. Arnett, Alicia W. Thompson, Kevin C. Johnson, Ankush Thakur, Lukas Valine, Christopher L. Pulliam, Brady N. Fetting, Rucha Gokul G. Samant, Andrew H. Houchins, Caleb C. Zarns
  • Publication number: 20210196948
    Abstract: Techniques are disclosed for delivering electrical stimulation therapy to a patient. In one example, a medical system delivers electrical stimulation therapy to a tissue of the patient via electrodes. The medical system determines a first response of a first sensed signal of the patient to the electrical stimulation therapy and a second response of a second sensed signal of the patient to the electrical stimulation therapy. Based on the first response and the second response for controlling the electrical stimulation therapy, the medical system selects one of the first sensed signal and the second sensed signal of the patient. The medical system adjusts a level of at least one parameter of the electrical stimulation therapy based on the selected one of the first sensed signal and the second sensed signal.
    Type: Application
    Filed: March 11, 2021
    Publication date: July 1, 2021
    Inventors: Scott R. Stanslaski, Timothy R. Abraham, Thomas Adamski, Timothy J. Denison, Robert S. Raike, Christopher L. Pulliam
  • Publication number: 20210196958
    Abstract: Devices, systems, and techniques are disclosed for managing electrical stimulation therapy and/or sensing of physiological signals such as brain signals. For example, a system may assist a clinician in identifying one or more electrode combinations for sensing a brain signal. In another example, a user interface may display brain signal information and values of a stimulation parameter at least partially defining electrical stimulation delivered to a patient when the brain signal information was sensed.
    Type: Application
    Filed: December 31, 2020
    Publication date: July 1, 2021
    Inventors: Evan D. Schnell, Scott R. Stanslaski, Ilan D. Gordon, Steven M. Goetz, Hijaz M. Haris, Eric J. Panken, Timothy R. Abraham, Thomas L. Chouinard, Susan E. Heilman Kilbane, Karan Chitkara, Christopher M. Arnett, Alicia W. Thompson, Kevin C. Johnson, Ankush Thakur, Lukas Valine, Christopher L. Pulliam, Brady N. Fetting, Rucha Gokul G. Samant, Andrew H. Houchins, Caleb C. Zarns
  • Patent number: 11045652
    Abstract: Techniques are described determining electrodes that are proximate or distal to location of an oscillatory signal source in a patient based on current source densities (CSDs). Processing circuitry may determine, for one or more electrodes of a plurality of electrodes, respective time-varying measurements of CSDs, aggregate, for the one or more electrodes of the plurality electrodes, the respective time-varying measurements of the CSDs to generate respective average level values for the one or more electrodes of the plurality of electrodes, determine, for one or more electrodes of the plurality of electrodes, respective phase-magnitude representations of the time-varying measurements of the CSDs. The respective phase-magnitude representations are indicative of respective magnitudes and phases of a particular frequency component of respective time-varying measurements of the CSDs.
    Type: Grant
    Filed: April 26, 2019
    Date of Patent: June 29, 2021
    Assignee: Medtronic, Inc.
    Inventors: Jadin C. Jackson, Yizi Xiao, Paula Andrea Elma Dassbach Green, Jianping Wu, Christopher L. Pulliam, Eric J. Panken, Robert S. Raike, Scott R. Stanslaski
  • Publication number: 20210093851
    Abstract: Techniques are disclosed for defining a homeostatic window for controlling delivery of electrical stimulation therapy to a patient. In one example, a method includes generating and delivering electrical stimulation therapy to tissue of a patient via electrodes. Further, the method includes adjusting a level of a parameter of the electrical stimulation therapy such that a signal of the patient is not less than a lower bound and not greater than an upper bound. The lower bound is determined to be the magnitude of the signal while receiving electrical stimulation therapy sufficient to reduce one or more symptoms of a disease while the patient was receiving medication for reduction of the one or more symptoms. Further, the upper bound is determined to be the magnitude of the signal while receiving electrical stimulation therapy sufficient to reduce the one or more symptoms when the patient was not receiving the medication.
    Type: Application
    Filed: November 30, 2020
    Publication date: April 1, 2021
    Inventors: Scott R. Stanslaski, Thomas Adamski, Duane L. Bourget, Timothy J. Denison, Benjamin P. Isaacson, Eric J. Panken, Jeffrey Herron
  • Patent number: 10960202
    Abstract: Techniques are disclosed for delivering electrical stimulation therapy to a patient. In one example, a medical system delivers electrical stimulation therapy to a tissue of the patient via electrodes. The medical system determines a first change of a first sensed signal of the patient to movement by the patient and a second change of a second sensed signal of the patient to the movement by the patient. Based on the first change and the second change, the medical system selects one of the first sensed signal and the second sensed signal of the patient for controlling the electrical stimulation therapy. The medical system adjusts a level of at least one parameter of the electrical stimulation therapy based on the selected one of the first sensed signal and the second sensed signal.
    Type: Grant
    Filed: September 25, 2017
    Date of Patent: March 30, 2021
    Assignee: Medtronic, Inc.
    Inventors: Scott R. Stanslaski, Timothy R. Abraham, Thomas Adamski, Timothy J. Denison, Robert S. Raike
  • Patent number: 10953222
    Abstract: Techniques are disclosed for delivering electrical stimulation therapy to a patient. In one example, a medical system delivers electrical stimulation therapy to a tissue of the patient via electrodes. The medical system determines a first response of a first sensed signal of the patient to the electrical stimulation therapy and a second response of a second sensed signal of the patient to the electrical stimulation therapy. Based on the first response and the second response for controlling the electrical stimulation therapy, the medical system selects one of the first sensed signal and the second sensed signal of the patient. The medical system adjusts a level of at least one parameter of the electrical stimulation therapy based on the selected one of the first sensed signal and the second sensed signal.
    Type: Grant
    Filed: September 25, 2017
    Date of Patent: March 23, 2021
    Assignee: MEDTRONIC, INC.
    Inventors: Scott R. Stanslaski, Timothy R. Abraham, Thomas Adamski, Timothy J. Denison, Robert S. Raike, Christopher Pulliam
  • Publication number: 20210060331
    Abstract: Techniques are disclosed for delivering electrical stimulation therapy to a patient. In one example, a medical system delivers electrical stimulation therapy to a tissue of the patient via electrodes. The medical system determines a first change of a first sensed signal of the patient to movement by the patient and a second change of a second sensed signal of the patient to the movement by the patient. Based on the first change and the second change, the medical system selects one of the first sensed signal and the second sensed signal of the patient for controlling the electrical stimulation therapy. The medical system adjusts a level of at least one parameter of the electrical stimulation therapy based on the selected one of the first sensed signal and the second sensed signal.
    Type: Application
    Filed: November 13, 2020
    Publication date: March 4, 2021
    Inventors: Scott R. Stanslaski, Timothy R. Abraham, Thomas Adamski, Timothy J. Denison, Robert S. Raike
  • Publication number: 20200406040
    Abstract: A medical device may receive sensor data from sensing sources, and determine confidence levels for sensor data received from each of the plurality of sensing sources. Each of the confidence levels of the sensor data from each of the sensing sources is a measure of accuracy of the sensor data received from respective sensing sources. The medical device may also determine one or more therapy parameter values based on the determined confidence levels, and cause delivery of therapy based on the determined one or more therapy parameter values.
    Type: Application
    Filed: September 10, 2020
    Publication date: December 31, 2020
    Inventors: William F. Kaemmerer, Duane L. Bourget, Timothy J. Denison, Eric J. Panken, Scott R. Stanslaski